Poison to the heart

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 331-332

  Kox, Matthijs ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardial dysfunction; Cytokines; Inflammation; Sepsis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA;

CYTOKINE RELEASE; DNA METHYLATION; EDITORIAL; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; MUSCLE CELL; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; ANIMAL; APOPTOSIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETICS; HEART ATRIUM; HEART MUSCLE CELL; METABOLISM; MOUSE; NOTE; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA METHYLATION; HEART ATRIA; MICE; MYOCYTES, CARDIAC; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74049091615     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b7838a     Document Type: Editorial

References (21)

1. Kimchi A, Ellrodt AG, Berman DS, et al: Right ventricular performance in septic shock: A combined radionuclide and hemo-dynamic study. J Am Coll Cardiol 1984; 4:945-951
2. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
3. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
4. Cunnion RE, Schaer GL, Parker MM, Natan-son C, Parrillo JE, et al: The coronary circulation in human septic shock. Circulation 1986; 73:637-644
5. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-1553
6. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
7. Pathan N, Hemingway CA, Alizadeh AA, et al: Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363:203-209
8. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-2312
9. van der PT, Romijn JA, Endert E, et al: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991; 261:E457-E465
10. Kapadia S, Lee J, Torre-Amione G, et al: Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995; 96:1042-1052
11. Stein B, Frank P, Schmitz W, et al: Endo-toxin and cytokines induce direct cardiode-pressive effects in mammalian cardiomyo-cytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996; 28:1631-1639
12. Thoenes M, Forstermann U, Tracey WR, et al: Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 1996; 28:165-169
13. Periasamy M, Huke S: SERCA pump level is a critical determinant of Ca(2+) homeostasis and cardiac contractility. J Mol Cell Cardiol 2001; 33:1053-1063
14. Zarain-Herzberg A, Afzal N, Elimban V, et al: Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 1996; 163-164: 285-290
15. Zedler S, Faist E: The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care 2006; 12: 595-601
16. Kubota T, Bounoutas GS, Miyagishima M, et al: Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 2000; 101:2518-2525
17. Lee SH, Chen YC, Chen YJ, et al: Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 2007; 80: 1806-1815
18. 2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med 2010; 38:217-222
19. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007; 128:683-692
20. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al: Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study. Lancet Oncol 2009; 10:223-232
21. Offner F, Philippe J, Vogelaers D, et al: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116:100-105